How to combine exosomes and biostimulators in one protocol

Why combine them

Exosomes and biostimulators answer different needs of the skin:

• An exosome combined with copper peptide works on repair: barrier, inflammation, tone and texture.
• A biostimulator works on structure: collagen, firmness and dermal density.

Many patients need both. Mature, photoaged skin often has a weakened barrier, uneven tone and loss of firmness all at once. Treating only one of those problems leaves the result half done. Combining them makes it possible to address the quality and the structure of the skin in the same plan.

The principle: repair first, then build

The rule that guides the protocol is simple: neocollagenesis performs better on healthy tissue. A biostimulator needs the fibroblast to respond in an orderly way; if the skin is inflamed, barrier-compromised or over-treated, the response is less predictable.

That is why the recommended order is:

1. Phase 1 — Repair with Exosome + GHK-Cu: repairs the barrier, calms the tissue and prepares the ground.
2. Phase 2 — Build with Exosome + PLLA: on healthy skin, poly-L-lactic acid stimulates collagen with the direction provided by the exosome.

That is what the combined protocol sums up as: "They don't compete. They go in order."

How to decide what each patient needs

A quick rule for the assessment:

• If the skin is losing firmness → biostimulation with PLLA.
• If the skin is damaged or irritated → repair with GHK-Cu.
• If it has both → combined protocol: GHK-Cu first, then PLLA.

Designing the protocol step by step

Step 1: initial assessment

• Barrier condition: tightness, stinging, erythema, flaking.
• Degree of laxity and dermal density.
• Tone, dark spots and texture.
• History, medications, recent treatments and contraindications.
• The patient's goals and timing.

Document with standardized photographs so you can compare at the end of each phase.

Step 2: repair phase

• Product: Exosome + GHK-Cu.
• Suggested schedule: 1 session every 14 days.
• Cycle: 3 sessions (1 box), extendable to 5 depending on response.
• Techniques: superficial mesotherapy, microneedling, dermapen, intradermal injection, mesotherapy gun or professional dermal roller.
• Exit goal: a recovered barrier, calm skin and a more even tone.

Step 3: assessment between phases

Before starting biostimulation, check that the skin is no longer inflamed or reactive. If some sensitivity remains, it is better to extend the repair phase. The interval between the last repair session and the first biostimulation session is set by the practitioner according to progress.

Step 4: build phase

• Product: Exosome + PLLA.
• Suggested schedule: 1 session every 4 weeks.
• Cycle: 3 sessions (1 box).
• Techniques: advanced facial mesotherapy, cannula infiltration, professional microneedling, dermapen and intradermal micro-injection.
• Exit goal: firmness and density that keep maturing for months.

Step 5: maintenance

• Biostimulation: every 3 to 6 months, per assessment.
• Skin quality: spaced repair sessions when the skin needs them, for example after summer sun exposure or after other procedures.

Example of an indicative calendar

This calendar is only a reference: frequency, number of sessions and the interval between phases must be individualized.

Three example cases

Case 1. A 48-year-old patient with photoaging and reactive skin. Mild laxity, superficial dark spots and stinging with almost any cosmetic. If biostimulation comes first, the skin responds with more inflammation and the patient drops out. Plan: 3 sessions of Exosome + GHK-Cu every 14 days; once the barrier has recovered, 3 sessions of Exosome + PLLA every 4 weeks; maintenance according to progress. Target result: calm and tone first, then firmness.

Case 2. A 42-year-old patient with healthy skin and loss of density. No inflammation or sensitivity; the concern is firmness along the jawline and neck. Plan: start directly with Exosome + PLLA, 3 sessions every 4 weeks, and keep repair sessions for after procedures or the sunny season. Not every patient needs both phases.

Case 3. A 35-year-old patient after fractional laser. They want a shorter recovery and, later on, better density. Plan: Exosome + GHK-Cu during laser recovery; once the skin has settled, consider a cycle of Exosome + PLLA if the firmness goal still applies.

These cases show that the combined protocol is not a fixed recipe but a logical order that adapts to each patient's starting point. The initial assessment defines where to begin; the assessment between phases defines when to move on. Keeping that logic explicit in the clinical file also makes the plan easy to resume if the patient pauses treatment for a few months.

What the patient gains from this order

• Better tolerance: biostimulation is applied to skin that is no longer reactive.
• A more complete result: both quality and structure are addressed, not just one.
• Visible progress: the repair phase shows changes from the first sessions, which keeps motivation up while collagen matures.
• A plan that makes sense: the patient understands why each phase comes when it does.

Combining with other treatments

The combined protocol fits in with other procedures in the patient's plan:

• Botulinum toxin: it relaxes the muscle; the biostimulator improves the dermis covering it. They enhance each other.
• Fillers: they correct localized volume; the protocol improves the quality and structure of the surrounding skin.
• Thread lifts: the biostimulator adds density and extends how long the result lasts.
• Laser, peels or microneedling: exosomes with GHK-Cu support recovery. See exosomes with microneedling, laser or peels.

It is wise to respect the intervals between procedures and avoid stacking treatments that inflame the skin in the same session.

Common mistakes

• Biostimulating inflamed or barrier-compromised skin.
• Skipping the assessment between phases and chaining treatments without reviewing the response.
• Expecting firmness results from the repair phase alone.
• Not planning maintenance, which shortens how long the result lasts.
• Not documenting each phase with photographs.

General precautions

Both products share contraindications: hypersensitivity to any component, pregnancy and breastfeeding, minors, active infection in the area, acute inflammatory processes, open wounds, active autoimmune disease, coagulation disorders and uncontrolled diabetes. PLLA is also contraindicated with a tendency to form keloids. PLLA is never administered intravascularly.

How to present it to the patient

"First we are going to repair your skin so it is healthy and calm. Then, on that foundation, we are going to stimulate your own collagen. That way each treatment works harder."

Presenting it in phases, with clear goals for each, makes it easier for the patient to complete the plan and appreciate the result.

How to measure progress in each phase

Each phase has its own success indicator. In the repair phase, what you measure is calm: less stinging, less redness and better tolerance to home products; a simple 0–10 scale the patient answers at each visit is enough. In the build phase, what you measure is structure: firmness to the touch, contour definition and skin quality in standardized photographs. Keeping the indicators separate avoids judging the repair phase by firmness, or the biostimulation by results that are not yet due.

Summary

Exosomes and biostimulators complement each other: exosomes with copper peptide repair and prepare the skin; the biostimulator with exosomes builds collagen on that foundation. The order —repair first, then build— improves tolerance and results, and turns the treatment into a plan with clear phases.

See the combined protocol, the profiles of Exosome + GHK-Cu and Exosome + PLLA, or contact our authorized distributors.

Frequently asked questions